ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ERK and Akt exhibit distinct signaling responses following stimulation by pro-angiogenic factors
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-17
DOI
10.1186/s12964-020-00595-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model
- (2019) Ding Li et al. Frontiers in Physiology
- Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis
- (2018) Yan Bai et al. CELLULAR IMMUNOLOGY
- The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment
- (2018) Ding Li et al. Integrative Biology
- Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
- (2018) Navid Sobhani et al. Cells
- Mechanistic insight into activation of MAPK signaling by pro-angiogenic factors
- (2018) Min Song et al. BMC Systems Biology
- Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis
- (2016) Kerri-Ann Norton et al. Scientific Reports
- Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway
- (2015) FENGYUN DONG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo
- (2014) Yan Bai et al. CELL AND TISSUE RESEARCH
- Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles
- (2014) Jitendra Kanodia et al. Cell Communication and Signaling
- Bevacizumab: A Review of Its Use in Advanced Cancer
- (2014) Gillian M. Keating DRUGS
- Quantitative Characterization of Cellular Membrane-Receptor Heterogeneity through Statistical and Computational Modeling
- (2014) Jared C. Weddell et al. PLoS One
- Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking
- (2013) Wan Hua Tan et al. CELLULAR SIGNALLING
- Regulation of Placental Angiogenesis
- (2013) Dong-bao Chen et al. MICROCIRCULATION
- Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
- (2013) Maria Vittoria Dieci et al. Cancer Discovery
- Signal Transduction by Vascular Endothelial Growth Factor Receptors
- (2013) S. Koch et al. Cold Spring Harbor Perspectives in Medicine
- Wound Healing Angiogenesis: Innovations and Challenges in Acute and Chronic Wound Healing
- (2012) Tatiana N. Demidova-Rice et al. Advances in Wound Care
- Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis
- (2011) S. Pisanti et al. BLOOD
- Chronic CRP-Exposure Inhibits VEGF-Induced Endothelial Cell Migration
- (2011) Christopher Schneeweis et al. Journal of Atherosclerosis and Thrombosis
- The US FDAs withdrawal of the breast cancer indication for Avastin (bevacizumab)
- (2011) Larry D. Sasich et al. SAUDI PHARMACEUTICAL JOURNAL
- Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
- (2010) M. O. Stefanini et al. CANCER RESEARCH
- Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis
- (2010) S. Iadevaia et al. CANCER RESEARCH
- Molecular Mediators of Angiogenesis
- (2010) Areck A. Ucuzian et al. Journal of Burn Care & Research
- Endothelial Cell Capture of Heparin-Binding Growth Factors under Flow
- (2010) Bing Zhao et al. PLoS Computational Biology
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- A Phosphoinositide 3-Kinase/Phospholipase Cgamma1 Pathway Regulates Fibroblast Growth Factor-Induced Capillary Tube Formation
- (2009) Tania Maffucci et al. PLoS One
- Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
- (2009) B. Schoeberl et al. Science Signaling
- Vascularization Strategies for Tissue Engineering
- (2009) Michael Lovett et al. TISSUE ENGINEERING PART B-REVIEWS
- Ligand-Stimulated VEGFR2 Signaling is Regulated by Co-Ordinated Trafficking and Proteolysis
- (2009) Alexander F. Bruns et al. TRAFFIC
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- (2008) Simeone Marino et al. JOURNAL OF THEORETICAL BIOLOGY
- New Role for the Protein Tyrosine Phosphatase DEP-1 in Akt Activation and Endothelial Cell Survival
- (2008) C. Chabot et al. MOLECULAR AND CELLULAR BIOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: II. Numerical simulations
- (2007) Sheng Tong et al. MICROVASCULAR RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started